Controlled delivery of a glutamate receptor modulator to promote regulatory T cells and restrain autoimmunity
<p> Autoimmunity occurs when the immune system incorrectly recognizes and attacks self-molecules. Current therapies involve broad immunosuppressants that are not curative and leave patients immunocompromised. Dendritic cells (DCs) are a target for new therapies because DCs influence the differ...
| Main Author: | |
|---|---|
| Language: | EN |
| Published: |
University of Maryland, College Park
2016
|
| Subjects: | |
| Online Access: | http://pqdtopen.proquest.com/#viewpdf?dispub=10012602 |